Skip to main content

Barriers to Widespread Access to Cancer Medications Include Excessive Cost

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 19, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Nov. 19, 2024 -- Barriers to widespread access to cancer treatments include excessive cost and lack of affordability, according to a review published online Nov. 18 in Cancer.

Arafat H. Tfayli, M.D., from the American University of Beirut Medical Center, and colleagues conducted a systematic review to examine the current state of cancer drug development, assessing the availability of drugs in different income countries.

The researchers note that an increase in cancer cases worldwide is projected, especially in low-income countries, where most cancer-related deaths are expected. The approval rate of cancer treatments has increased, but significant barriers to widespread access are posed by their excessive cost and lack of affordability. Geographic location and procurement connections influence disparities in the costs of crucial cancer medications. Sharing production secrets, implementing price discrimination, international funding, improved primary health care measures, and implementation of cost-effective screening methods are potential solutions for addressing the inequity in drug distribution.

"Accessibility to effective cancer treatments needs to become a fundamental human right that transcends borders and one that could become economically affordable. All parties should collaborate to ensure that the principle of beneficence is well applied," the authors write. "In the 21st century, it cannot and should not be a medical disadvantage to be born in a low‐income country."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted November 2024

Read this next

Generative AI Model for Draft Radiological Reporting Improves Documentation Efficiency

THURSDAY, June 12, 2025 -- Clinical use of artificial intelligence (AI)-generated draft radiograph reports is associated with improved radiologist documentation efficiency while...

Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance

THURSDAY, June 12, 2025 -- For patients with metastatic melanoma, mitochondrial (MT) haplogroup T (HG-T) is associated with resistance to an anti-programmed cell death...

Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors

THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.